Pennsylvania Biotechnology Center Responsible for 573 Jobs and $579 Million

  Pennsylvania Biotechnology Center Responsible for 573 Jobs and $579 Million

(Economic Impact Study Reveals Huge Benefits for the Community of Bucks County
                              and Pennsylvania)

Business Wire

DOYLESTOWN, Pa. -- March 8, 2013

The Pennsylvania Biotechnology Center, in Doylestown, Pa., managed and
established by the Hepatitis B Foundation in 2006 and co-owned with Delaware
Valley College, proudly unveils a 2013 Economic Impact Study by Byler
Associates, LLC showing impressive results. The news is good, especially for
the Bucks County community and State of Pennsylvania as a whole. According to
the report, the current total economic impact from the Pennsylvania
Biotechnology Center and its affiliated organizations from 2009 through 2012
amounts to $579 million for the Commonwealth of Pennsylvania and 573 jobs.

The future vision of the Pennsylvania Biotechnology Center, a nonprofit
research organization dedicated to the creation of a world-class biotechnology
center, is the same as it was at its inception – growth. The plan is to
continue to build an even stronger community consisting of high-value
personnel in Doylestown that will be known in the region and the state as a
true accelerator of biotechnology growth.

“We promised we would deliver,” said Dr. Timothy Block, president of the
Pennsylvania Biotechnology Center, Hepatitis B Foundation and its Institute
for Hepatitis and Virus Research and as well as professor of Microbiology,
Drexel University College of Medicine. “Since its creation in 2006, the
Pennsylvania Biotechnology Center has been an economic driver that has
increased jobs and revenue in Bucks County and the State of Pennsylvania. Not
to mention the many new discoveries from our Center that are now entering
human use studies and can help people. All of this highlights the reason to
continue to promote the successful investment in the Center since it has
prospered during a slow economic period and weathered the most recent economic
situation so well.”

According to the 2013 report, nearly 90 percent of the Pennsylvania
Biotechnology Center’s aggregate impact ($507 million) accrues to Bucks
County, Pa., while an additional $72 million spills over to benefit the
Commonwealth at large. In regards to job creation, the Center’s labor impact
includes 573 jobs with 263 jobs directly associated with the Center and 310
indirect jobs (184 in Bucks County and 126 jobs elsewhere in the state) as a
result of additional spending and output.

Jim Greenwood, president and CEO of Biotechnology Industry Organization (BIO)
– the nation’s leading advocacy organization for more than 1,200 organizations
– and the region’s former congressman during the time when the Pennsylvania
Biotechnology Center was established, notes that, “The Pennsylvania
Biotechnology Center is a true success story. We started with an abandoned
warehouse which had lost 140 jobs and converted it to a high-tech incubator of
innovation. The result: hundreds of jobs and millions of dollars of economic
development in a field that brings hope to untold numbers of patients."

The study’s findings could not be better news for State Senator Chuck
McIlhinney (R-Bucks) who has supported the Pennsylvania Biotechnology Center
from the beginning. He said, “The Pennsylvania Biotechnology Center is a major
asset to Bucks County and to the State of Pennsylvania. The Center serves as
an incubator for new jobs, new technologies and thriving commercial
development for our region. It is as economically important as it is

At its founding, the Pennsylvania Biotechnology Center was a closed warehouse,
converted into a state-of-the-art research facility to accelerate its research
mission, to nurture biotech start-up companies in Bucks County, Pa., to
promote regional economic development and job creation and to educate and
train tomorrow’s researchers. Now, there are more than 47 organizations at the
Center, including 40 small start-ups, with some based on scientists’ ideas
from the Institute for Hepatitis and Virus Research and Drexel University, and
many from pharma and biotech professionals who were displaced from companies
and came to the Center because of the environment which is supportive of
biotech entrepreneurs.

For example, Dr. Kunwar Shailubhai, Chief Scientific Officer of Synergy
Pharmaceuticals, Inc. – a company at the Center that has grown to a value of
more than $480 million – describes the Center as “…an excellent atmosphere for
scientific research as well as for interaction with other scientists and
entrepreneurs…(the facility) provides the space we need to advance our
discovery portfolio and outstanding networking opportunities.” He added that
the Center is a magnet for attracting and recruiting talented scientists who
reside in the region which contributes to the Center’s success in making a
positive economic impact.

View a video summarizing the Pennsylvania Biotechnology Center 2013 Economic
Impact Study.

About the Pennsylvania Biotechnology Center: The Pennsylvania Biotechnology
Center is a nonprofit research organization created and managed by the
Hepatitis B Foundation, and owned in partnership with Delaware Valley College,
that is dedicated to the creation of a world-class biotechnology center, to
the promotion of regional economic development and job creation, and to the
education and training of tomorrow’s researchers. To learn more, visit

About the Hepatitis B Foundation: The Hepatitis B Foundation is the only
national nonprofit organization solely dedicated to finding a cure for
hepatitis B and improving the quality of life for those affected worldwide
through research, education and patient advocacy. To learn more, visit, follow us on Twitter @HepBFoundation, find us on Facebook at or call (215) 489-4900.


Pennsylvania Biotechnology Center
Gina Rubel, 215-340-0480
Press spacebar to pause and continue. Press esc to stop.